SCHEMBL1334904

SCHEMBL1334904

CCC(=O)Nc1cc[nH]c(=O)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 15/20 0.43
▸ ADORA1 P30542 10/20 0.43
▸ ADORA2A P29274 10/20 0.43
▸ ADORA2B P29275 7/20 0.43
▸ HTR1F P30939 2/20 0.43
▸ HTR1A P08908 1/20 0.41
▸ HTR1D P28221 1/20 0.41
▸ HTR1B P28222 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ HTR1E P28566 1/20 0.41
▸ HTR6 P50406 1/20 0.41
▸ HTR4 Q13639 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10931578 0.87 ADORA3 (0.46) ADORA3ADORA1ADORA2AADORA2BHTR1F
SCHEMBL16774439 0.84 SMN1; SMN2 (0.51) ADORA3ADORA1HTR1FNPC1RAB9A
SCHEMBL11015102 0.83 NPC1 (0.51) ADORA3ADORA1HTR1FHTR1DHTR1B
SCHEMBL21219850 0.83 ALDH1A1 (0.45) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
Ribose (Furanose) SCHEMBL11397241 0.82 OGA (0.44) HTR1FHTR1AHTR1DHTR1BHTR2A
SCHEMBL13892050 0.82 PARP1 (0.51) ADORA1ADORA2AALDH1A1SMN1; SMN2
SCHEMBL1966349 0.82 SMN1; SMN2 (0.37) ADORA3ADORA1ADORA2AHTR1FNPC1
SCHEMBL11018471 0.82 DEGS1 (0.53) HTR1FHTR1DHTR1BNPC1POLB
SCHEMBL11016976 0.82 DEGS1 (0.53) HTR1FHTR1DHTR1BNPC1POLB
SCHEMBL3626598 0.82 DEGS1 (0.53) HTR1FHTR1DHTR1BNPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024123-A1 NOVEL CITICOLINE DERIVATIVES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-30 — — WO claimed
CN-108409818-B Method for synthesizing cytosine nucleoside 新乡拓新药业股份有限公司 2020-09-11 — — CN claimed
WO-2025024123-A1 NOVEL CITICOLINE DERIVATIVES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-30 — — WO disclosed
WO-2024250607-A1 CHEMICALLY MODIFIED CYTIDINE TRIPHOSPHATE AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院深圳先进技术研究院 2024-12-12 — — WO disclosed
WO-2024250923-A1 CHEMICALLY MODIFIED NUCLEOSIDE, CHEMICALLY MODIFIED NUCLEOSIDE TRIPHOSPHATE AND USE THEREOF 中国科学院深圳先进技术研究院 2024-12-12 — — WO disclosed
CN-119080855-A Chemically modified cytosine nucleoside triphosphate and preparation method and application thereof 中国科学院深圳先进技术研究院 2024-12-06 — — CN disclosed
EP-3184112-B1 SYNTHETIC INTERMEDIATE OF 1-(2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSYL)CYTOSINE FUJIFILM CORP (JP) 2020-12-23 — — EP disclosed
CN-108409818-B Method for synthesizing cytosine nucleoside 新乡拓新药业股份有限公司 2020-09-11 — — CN disclosed
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same FUJIFILM CORPORATION (JP) 2020-02-25 — — US disclosed
US-20180327377-A1 SYNTHETIC INTERMEDIATE OF 1-(2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSYL)CYTOSINE, SYNTHETIC INTERMEDIATE OF THIONUCLEOSIDE, AND METHOD FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2018-11-15 — — US disclosed
CN-104447923-B Methyl nucleoside derivatives of 2 ' deoxidation, 2 ' fluorine 2 ' and preparation method thereof and the purposes in pharmacy 中国药科大学 2018-03-30 — — CN disclosed
US-7371818-B2 Polypeptide and DNA thereof SHIONOGI & CO., LTD. (JP) 2008-05-13 — — US disclosed
EP-1354890-B1 CHORDIN-LIKE POLYPEPTIDES AND DNA THEREOF SHIONOGI & CO (JP) 2007-08-08 — — EP disclosed
WO-2007030890-A1 A MARKER FOR PROLONGED RUPTURE OF MEMBRANES BIO SOURCE (WUHAN) TECHNOLOGY LTD (CN) 2007-03-22 — — WO disclosed
WO-2007030889-A1 METHOD OF DIAGNOSING PRE-ECLAMPSIA VOROTELIAK VICTOR (AU) 2007-03-22 — — WO disclosed
US-20050158719-A1 Using tumor maker protein as diagnostic/prognostic tool in detection of neovascularization, vascular, inflammatory, reproductive system, central nervous and cell proliferative disorders SHIONOGI & CO., LTD. (JP) 2005-07-21 — — US disclosed
US-20040110921-A1 Novel polypeptide and dna thereof SHIONOGI & CO., LTD. (JP) 2004-06-10 — — US disclosed
EP-1391512-A1 POLYPEPTIDE SERVING AS ANGIOGENIC MARKER AND DNA THEREOF SHIONOGI & CO., LTD. (JP) 2004-02-25 — — EP disclosed
EP-1354890-A1 NOVEL POLYPEPTIDE AND DNA THEREOF SHIONOGI & CO., LTD. (JP) 2003-10-22 — — EP disclosed
EP-0136693-A2 Production of cytidine derivatives Takeda Chemical Industries, Ltd. (JP) 1985-04-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same TYMS, TYMP, RRM2B ADORA3 436/4885ADORA1 282/4885ADORA2A 464/4885
US-20180327377-A1 SYNTHETIC INTERMEDIATE OF 1-(2-DEOXY-2-FLUORO-4-THIO-ß-D-ARABINOFURANOSYL)CYTOSINE, SYNTHETIC INTERMEDIATE OF THIONUCLEOSIDE, AND METHOD FOR PRODUCING THE SAME TYMS, TYMP, RRM2B ADORA3 427/4885ADORA1 281/4885ADORA2A 457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback